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ABSTRACT
The present study shows that arsenic induces
GADD45a (growth arrest and DNA damage inducible
gene 45a) mainly through post-transcriptional mecha-
nism. Treatment of the human bronchial epithelial
cell line, BEAS-2B, with arsenic(III) chloride (As31)
resulted in a significant increase in GADD45a protein
and mRNA. However, As31 only exhibited a marginal
effect on the transcription of the GADD45a gene.
The accumulation of GADD45a mRNA is largely
achieved by the stabilization of GADD45a mRNA in
the cellular response to As31. As31 is able to induce
binding of mRNA stabilizing proteins, nucleolin
and less potently, HuR, to the GADD45a mRNA.
Although As31 was unable to affect the expression
of nucleolin, treatment of the cells with As31 resulted
in re-distribution of nucleolin from nucleoli to nucleo-
plasm. Silencing of the nucleolin mRNA by RNA
interference reversed As31-induced stabilization of
the GADD45a mRNA and accumulation of the
GADD45a protein. Stabilization of GADD45a mRNA,
thus, represents a novel mechanism contributing to
the production of GADD45a and cell cycle arrest in
response to As31.
INTRODUCTION
Growth arrest and DNA damage inducible gene 45a
(GADD45a) is a widely expressed, inducible nuclear protein
that plays critical role in the checkpoint function of cells in
response to a wide spectrum of DNA-damaging or stress sig-
nals (1). GADD45a has been shown to inhibit cyclin B/CDC2,
a key protein kinase complex governing G2/M transition of the
cell cycle (2). In addition, GADD45a is an important protein
involved in genomic stability by its contributions to DNA
excision repair (3). Furthermore, GADD45a has been impli-
cated in cell apoptosis, cell survival and innate immunity (4,5).
The human GADD45a is an acidic protein composed of 165
amino acids, with some similarities to GADD45b, GADD45g
and ribosomal protein S12. In addition to binding to cyclin
B/CDC2 as originally demonstrated (2), GADD45a is also
capable of interacting with proliferating cell nuclear antigen
(6), p21 (7), histone proteins (8), TAFII70 (9), p38 (10) and
MTK1/MEKK4 (11), a MAPK kinase kinase that can activate
JNK and p38 subgroups of MAP kinase.
The transcriptional regulation of GADD45a has been exten-
sively studied during the past several years. The best-studied
transcriptional regulator for the expression of GADD45a is
the tumor suppressor protein, p53 (6). In response to ionizing
radiation or methyl methansulfonate, GADD45a was rapidly
up-regulated through a p53-dependent mechanism. A consen-
sus p53 binding site has been identified in the third intron
region of the GADD45a gene. Ionizing radiation or certain
other DNA-damaging signals induce binding of p53 to this
site, followed by the recruitment of acetyltransferase p300/
CBP and protein arginine methyltransferases PRMT1 or
CARM1 to this region to stimulate the transcription of
GADD45a (12). The promoter region of GADD45a lacks a
consensus p53 binding site. However, p53 can also stimulate
the transcription of GADD45a by forming a complex with
WT1 that binds directly to the proximal promoter of
GADD45a (13). Other transcription factors that possibly
contribute to a p53-independent regulation of GADD45a
include FoxO3a (14), Oct1 (15), C/EBPa (16), Egr-1 (17),
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POU family members (18), and two transcriptional repressors
of GADD45a, c-myc (19) and ZBRK (20).
Arsenic is a naturally occurring metalloid that exhibits
potent carcinogenic effects in mammals (21,22). It exists in
both inorganic and organic forms with different oxidation
states (23). The primary forms of arsenic in environment
are the inorganic trivalent (As3+) and pentavalent arsenic
(As5+). Humans are exposed to arsenic mainly through oral
consumption of contaminated water, food or drugs, and inhala-
tion of arsenic-containing dust or smoke in several occupa-
tional settings. Paradoxically, arsenic has also been used as an
effective single therapeutic agent for several tumors, espe-
cially acute promyelocytic leukemia (24). However, the
molecular mechanisms of arsenic-induced carcinogenesis or
arsenic-induced remissions of tumors are not fully understood.
We and others have previously shown that arsenic is a potent
inducer of GADD45a expression in human cells (25,26). We
have also shown that activation of c-Jun N-terminal kinase
(JNK) might be partially responsible for the induction of
GADD45a by arsenic (27). The involvement of JNK in
GADD45a expression was further confirmed in the cellular
response to UV radiation (28) or a PPARg agonist, troglita-
zone (29). In an attempt to gain insight into the detailed
mechanism of arsenic-induced expression of GADD45a, we
examined the transcriptional and post-transcriptional regula-
tions of GADD45a expression in human bronchial epithelial
cells subjected to arsenic exposure. The data presented here
reveal that the arsenic-induced expression of GADD45a is
mainly regulated by post-transcriptional mechanism in
which the mRNA of GADD45a was bound and stabilized
by the RNA binding proteins, mainly nucleolin.
MATERIALS AND METHODS
Cell culture, transfections and luciferase assays
The human bronchial epithelial cell line, BEAS-2B, was pur-
chased from American Tissue Culture Collection (Manassas,
VA) and maintained in DMEM supplemented with 5% fetal
calf serum and grown at 37C, 5% CO2 in a humidified incu-
bator. Transfections were performed using lipofectamine 2000
as suggested by the manufacturer (Invitrogen, Carlsbad, CA).
The human GADD45a promoter and intron 3 luciferase
reporter constructs were provided by Dr Albert J. Fornace
at National Institutes of Health (NIH, Bethesda, MD). In
these vectors, the GADD45a promoter region from 994
to +26 and the entire intron 3 region were inserted into the
upstream of the luciferase reporter gene, respectively. Cells
were harvested at 36 h and analyzed for luciferase activity
using the Promega Dual-Luciferase Assay System (Promega,
Madison, WI). The data shown are the mean of at least three
independent experiments with error bars displaying standard
deviations.
Cell treatment and western blotting
The BEAS-2B cells were seeded in 6-well tissue plates at a
density of 2 · 105 cells/well and cultured for 60 h. The cells
were treated with the indicated concentrations of arsenic(III)
chloride (As3+) (Sigma-Aldrich, St Louis, MO) or H2O2
(Sigma, MO) in the absence or presence of 10 mM
N-acetyl-L-cysteine (NAC) (Sigma, MO). Total cell lysate
was prepared as described previously (30). Twenty-five micro-
grams of the protein lysate from the cells cultured in the
absence or presence of As3+ were analyzed by SDS–PAGE
and immunoblotted with the indicated antibodies. The anti-
bodies against GADD45a, actin, nucleolin, HuR and IKKg
were purchased from Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA). The antibodies against phospho-FoxO3a, total
FoxO3a, phospho-Akt and total Akt were purchased from
Cell Signaling (Beverly, MA).
RT–PCR
The levels of GADD45a and GAPDH mRNA in cell lysate or
immune complex were determined by RT–PCR using the
AccessQuick RT–PCR system (Promega, Madison, WI).
The cells cultured in 6-well tissue culture plates were washed
with phosphate-buffered saline (PBS) and lysed using cell
lysis buffer from Cells-to-cDNA II kit (Ambion, Austin,
TX) as suggested by the manufacturer. RT–PCR was per-
formed using 3 ml of cell lysate and primer sets as follows:
GADD45a sense: 50-GGAGAGCAGAAGACCGAAA-30 and
GADD45a antisense: 50-TCACTGGAACCCATTGATC-30;
GAPDH sense: 50-CTGAACGGGAAGCTCACTGGCAT-
GGCCTTC-30 and antisense: 50-CATGAGGTCCACCACCC-
TGTTGCTGTAGCC-30.
Real-time RT–PCR
To verify the results of RT–PCR, a quantitative real-time
RT–PCR was performed. The GADD45a mRNA levels
were measured using TaqMan primers designed using
Universal Probe Library Assay Design Center (http://www.
roche-applied-science.com/sis/rtpcr/upl/adc.jsp) with the
ABI 7500 Sequence Detector (PE Applied Biosystems, Foster
City, CA). The primers for GADD45 (Accession no. L24498)
were forward, 50-TCAGCCCAGCTACTCCCTAC; reverse,
50-AATCTGCCCTGCTAAAGGAAT, used with Universal
Probe #16. The primers for the house-keeping gene
GAPDH (NM_002046) were forward, 50-AGCCACATC-
GCTCAGACAC; reverse, GCCCAATACGACCAAATCC,
used with Universal Probe #60. Total RNA was isolated
using RNAqueous	 -4PCR kits (Ambion, Austin, TX)
from BEAS-2B cells (2 million cells) cultured in the absence
or presence of 20 mM As3+ for 1–8 h. One to two micrograms
of the DNAse I-treated RNA was reverse transcribed, using
Superscript II (Life Technologies, Gaithersburg, MD). The
cDNA generated was diluted 1:100 and 15 ml was used to
conduct the PCR according to the TaqMan Master mix
PCR kit instructions. The comparative CT (threshold cycle)
method was used to calculate the relative concentrations (User
Bulletin #2, ABI PRISM 7700 Sequence Detector, PE
Applied Biosystems, Foster City, CA). Briefly, the method
involves obtaining the CT values for the GADD45a
mRNA, normalizing to a house-keeping gene, GAPDH, and
deriving the fold increase compared with control, unstimulated
cells.
RNA immunoprecipitation assay
BEAS-2B cells were cultured in the absence or presence of
20 mM As3+ for 4 h and subjected to RNA immunopre-
cipitation assay as described previously (31,32) with minor
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modifications. Briefly, cells were lysed in 500 ml of cell lysis
buffer containing 20 mM Tris–HCl (pH 7.5), 150 mM NaCl, 1
mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium
pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na3VO4 and
1 mg/ml of leupeptin for 30 min at 4C. Cell debris in
the lysates was removed by centrifugation at 14 000 g for
15 min at 4C. The supernatants were incubated overnight
with the indicated antibodies at 4C under rotation. The
protein–mRNA binding complex was immunoprecipitated
by incubation of the lysates with Protein A-Agarose for 4 h at
4C. The immune complex was washed three times in lysis
buffer. The mRNA of GADD45a and GAPDH in both the
immune complex and supernatant were determined by RT–PCR.
Immunofluorescence staining
BEAS-2B cells were seeded into 24-well tissue culture plate
without glass slides at a concentration of 5000 to 10 000 cells/
well and cultured for 24 h. The cells were then either untreated
or treated with As3+ for an additional 4 h. The cells were fixed
directly in the culture plate by 10% formalin and permeabi-
lized with 0.1% Triton X-100 for 10 min at room temperature,
respectively. Cells were incubated for 6 h at 4C with primary
antibody diluted (1:100) in PBS containing 5% BSA. After
extensive washing with PBS, cells were incubated with
Fluorescein (FITC)-conjugated anti-rabbit IgG (Santa Cruz,
CA) in 1:100 dilution in PBS containing 5% BSA and
1 mg/ml of propidium iodide (PI) for 1 h at room temperature.
Fluorescein images were captured by using a Zeiss
Axiovert100 microscope connected with a Pixera Pro150ES
digital camera.
RNA interference
The target sequencing of small interference RNA (siRNA)
against human nucleolin was selected based on the criteria
described by Reynolds et al. (33) using a siRNA design
program, Gene-specific siRNA selector, developed by Wistar
Bioinformatics (http://biowww.net/detail-574.html). The
siRNA targeting region is 983-aaagaaggaaatggccaaaca-1001
(NM_005381). The control siRNA and siRNA transfection
was described previously (34).
RESULTS
As3+ induces accumulation of GADD45a protein
We have previously shown that As3+ induced cell cycle arrest
at the G2/M phase, which correlated with the induction of
GADD45a protein (25). To obtain insight into the possible
mechanism of As3+-induced GADD45a, the cells were pre-
treated with 10 mM N-acetyl-cysteine (NAC), a widely used
antioxidant that provides cells with exogenous glutathione
(GSH) precursor, for 12 h and then treated with 0–20 mM
As3+ for an additional 12 h. The expression of GADD45a
was barely detectable in the cells without As3+ treatment
(Figure 1A). The induction of GADD45a by As3+ was
dose-dependent. A plateau of GADD45a induction was
reached when the cells were treated with 20 mM As3+. Further
elevation of As3+ concentrations (more than 50 mM) did not
increase the expression of GADD45a due to cytotoxicity (data
not shown). Pre-treatment of the cells with 10 mM NAC
completely blocked the induction of GADD45a by As3+
(Figure 1A, lanes 7–12), suggesting that As3+-induced
GADD45a expression is possibly through either an oxidative
stress response or a direct depletion of GSH. In an additional
experimental setting, we pre-treated cells with increasing
concentrations of aspirin, another antioxidant which acts as
a free radical scavenger, and found that the induction of
GADD45a by As3+ was partially inhibited by 10–20 mM
aspirin (data not shown).
The inhibition of As3+-induced GADD45a by NAC and
aspirin implies a possible involvement of reactive oxygen
species in this process. Indeed, our previous report had demon-
strated a substantial accumulation of H2O2 in the cells treated
with As3+ (30). To determine whether H2O2 itself is able to
induce GADD45a, the cells were treated with 50–800 mM
H2O2 for 12 h. Figure 1B indicates that the induction of
GADD45a by H2O2 is very marginal in comparing with
Figure 1. As3+ induces expression of GADD45a protein. (A) BEAS-2B cells
were pre-treated with 10 mM NAC for 12 h and then incubated in the absence or
presence of different concentrations of As3+ for an additional 12 h. Total cell
lysates were subjected to western blotting for the determination of GADD45a
(upper panel) and actin (bottom panel), respectively. (B) Cells treated with the
indicated concentrations of H2O2 for 12 h and then subjected to western blotting
for GADD45a (upper panel) or actin (lower panel). Data are representative of at
least four experiments. (C) Densitometry scanning of the GADD45a bands
induced by As3+ and H2O2 in four separate experiments. (D) Cells transfected
with GADD45a promoter- or intron3-luciferase reporter construct for 36 h and
then treated with the indicated concentrations of As3+ (left panel) or H2O2 (right
panel) for an additional 12 h. Total cell lysates were used for luciferase activity
analysis. Asterisks indicate statistically difference with a value of P < 0.05.
Data are representative of at least three experiments.
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the cells treated with As3+. An appreciable induction of
GADD45a could be observed only in the cells treated with
400–800 mM H2O2 (Figure 1B, lanes 5 and 6, upper panel). At
this concentration, however, the cells showed cytotoxic
responses as indicated by the notable cell death determined
microscopically (data not shown). Densitometry analysis of
the GADD45a protein bands in four separate experiments
indicated a more than 20-fold induction of the GADD45a
by 20 mM As3+ and a 3- to 4-fold induction of the
GADD45a by 800 mM H2O2, respectively (Figure 1C).
As3+ has a weak effect on the transcription of
GADD45a gene
Earlier studies have indicated that the consensus p53 binding
site in the third intron region of the human GADD45a gene is
critical for the genotoxic stress-induced expression of
GADD45a (12). It is unclear whether As3+ induces
GADD45a expression through transcriptional regulation in
a manner of either p53-dependent or p53-independent. By
the use of GADD45a promoter- and intron3-based luciferase
reporter gene vectors, we noted that As3+, at 20 mM, only
induced 3- and 2-fold increase of GADD45a promoter-
luciferase activity and GADD45a intron3-luciferase activity,
respectively (Figure 1D, left panel). Similar to that of
immunoblotting (Figure 1B), H2O2 exhibited no significant
induction on the GADD45a promoter-luciferase activity at
each dose point tested (Figure 1D, right panel). Only about
1.5-fold induction of intron3-luciferase activity was observed
in the cells treated with 400–800 mM H2O2 (Figure 1D, right
panel).
There is considerable limitation in reporter gene-based tran-
scriptional analysis due to the absence of distant transcription
enhancer elements in the reporter constructs. To address
whether As3+ truly regulates the transcription of the
GADD45a gene, we next performed a RT–PCR-based nuclear
run-on assay. Since we had demonstrated that the accumula-
tion of the GADD45a mRNA was peaked by a 4 h As3+
treatment (following), we incubated the cells with 20 mM
As3+ for 4 h in this nuclear run-on assay. Exposure of the
cells to As3+ did not induce an appreciable transcription in
this assay (data not shown). Thus, these data indicate that it is
unlikely that transcriptional regulation is the main mechanism
of As3+-induced expression of the GADD45a.
Inhibition of Akt has marginal effect on the expression
of GADD45a induced by As3+
Akt signaling pathway is best known for its ability to
counteract stress responses that lead to growth arrest or cell
apoptosis (35). As a serine-threonine kinase, Akt is able to
phosphorylate and inactivate proteins involved in cell cycle
arrest or apoptosis. These proteins include FoxO3a, GSK3,
Bad, eNOS and procaspase-9 (36). In response to DNA
damage signals, FoxO3a appears to be the key transcription
factor that up-regulates the transcription of GADD45a (14).
Phosphorylation of FoxO3a by Akt suppresses the transcrip-
tional activity of FoxO3a on the expression of GADD45a
gene. Thus, inhibition of Akt, a negative regulator of
FoxO3a, might indirectly contribute to the induction of
GADD45a. To test whether As3+-induced GADD45a is
through its effect on Akt-FoxO3a pathway in human epithelial
cells, the phosphorylation status of Akt and FoxO3a was
investigated in the cells treated with As3+ for different time
periods. Induction of GADD45a occurred at 4–20 h of As3+
treatment (Figure 2A). A significant increase, rather than
decrease of phosphorylation of FoxO3a and Akt, was observed
at these time points. Thus, these results suggest that As3+-
induced GADD45a is not through the inhibition of Akt in
the human epithelial cells. In contrast, As3+ induces activation
of Akt that subsequently phosphorylates and inactivates
FoxO3a, which offsets the effect of As3+ on the induction
of GADD45a.
We observed an increase in the phosphorylation of Akt and
FoxO3a in the cellular response to As3+. Thus, it is worth
testing whether inhibition of Akt amplifies the As3+-induced
expression of GADD45a. Ly294002, a relatively specific
inhibitor for phosphatidylinositol 3 kinase (PI3K), could com-
pletely block the activation of Akt and substantially, decrease
the phosphorylation of FoxO3a (Figure 2B). However, only
about 1- to 2-fold increase of GADD45a induction by As3+
was observed in the cells pre-treated with 10 mM Ly294002
(Figure 2B). Similarly, in a GADD45a promoter-based
luciferase activity analysis, only a marginal amplification of
Figure 2. As3+ induces activation of Akt and phosphorylation of FoxO3a.
(A) Cells treated with 20 mM As3+ for the indicated times. Total cell lysates
were subjected to western blotting for GADD45a, actin, phospho-FoxO3a,
total FoxO3a, phospho-Akt and total Akt. (B) Cells were pre-treated with
vehicle solution, DMSO, or 10 mM PI3K inhibitor, Ly294002 (Ly), for 2 h
and then treated with 20 mM As3+ for the indicated times. Total cell lysates were
used for the detection of expression of GADD45a, phosphorylation of FoxO3a
and activation of Akt. (C) Cells transfected with a GADD45a promoter-
luciferase reporter for 36 h and then treated with 20 mM As3+ in the absence
or presence of 10 mM Ly294002 for an additional 12 h. Luciferase activity
was calibrated by protein concentrations and the cell viability. Data show
means ± standard deviations of three experiments.
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As3+-induced luciferase activity could be seen in the cells
pre-treated with Ly294002 (Figure 2C). Thus, these observa-
tions suggest that although As3+ is capable of stimulating the
activation of Akt, a negative regulator for FoxO3a and
the subsequent transcription of GADD45a gene, inhibi-
tion of Akt has a very weak effect on the induction of
GADD45a by As3+.
As3+ induces accumulation GADD45a mRNA
To demonstrate the correlation between the levels of protein
and gene expression, the effect of As3+ on the induction of
GADD45amRNA was determined by RT–PCR. A substantial
induction of GADD45a mRNA was observed in the cells
treated with 20 mM As3+ for 1–6 h (Figure 3A). After 8 h,
the GADD45a mRNA was declined to the basal level,
indicating turnover of mRNA. The PCR primers we used
correspond to the exon1 and exon4 region of the
GADD45a gene, respectively, which amplify a fragment of
GADD45a mRNA with a size of 453 bp (Figure 3A, frag-
ment a). Interestingly, two additional fragments with size of
430 bp and 350 bp were observed in this RT–PCR analysis
(Figure 3A, fragments ‘b’ and ‘c’), possibly resulted from
mRNA alternative splicing. DNA sequencing indicated that
the fragment ‘a’ is indeed the full-length GADD45amRNA as
expected. The fragment ‘c’ was resulted from the splicing out
of the entire exon2 region (GenBank ID DQ008445), whereas
the sequencing of fragment ‘b’ was inclusive (data not shown).
The accumulation of the GADD45a mRNA induced by As3+
was further verified by a quantitative real-time RT–PCR.
In fully agreement with the results of the traditional
RT–PCR, a 6- to 10-fold induction of the GADD45a
mRNA was observed in the cells treated with As3+ for
1–4 h (Figure 3B).
As3+ does not affect the degradation of
GADD45a protein
We have observed a more than 10- to 20-fold induction of
GADD45a protein and 6- to 10-fold increase of GADD45a
mRNA by As3+ in our western blotting and RT–PCR experi-
ments, respectively (Figures 1–3). However, we have failed
to observe a significant transcriptional induction of the
GADD45a gene by As3+ in both promoter/intron3 luciferase
activity assay and nuclear run-on assay (Figure 1D and data
not shown). In several other experimental settings, we have
also tested the effect of As3+ on some different GADD45a
promoter constructs that contain 1–2 kb promoter regions.
In these experiments, we have failed to observe a more than
a 3-fold induction of these promoter-luciferase activities
by As3+ (D. Bhatia, V. Castranova and F. Chen, manuscript
in preparation). Thus, we assume that As3+-induced
GADD45a might be mainly through post-transcriptional
mechanisms including alterations in mRNA or protein sta-
bility. We have failed to determine the protein stability of
GADD45a by using cycloheximide (data not shown), since
the GADD45a protein was barely detectable in the cells
without As3+ treatment (Figures 1 and 2).
One possibility that As3+ induces accumulation of
GADD45a protein is through interfering with either the ubiq-
uitination of or the subsequent proteasome-mediated degrada-
tion of GADD45a. We have previously shown that As3+
induced proteasomal degradation of Cdc25C protein (37).
Therefore, it is unlikely that As3+ induces GADD45a through
inhibiting the proteolytic activity of the proteasome. To test
whether As3+ is able to interfere with the process of
GADD45a ubiquitination, the cells were pre-treated with a
proteasome inhibitor, MG132, for 2 h and then treated with
As3+ for 12 h. The ubiquitination of proteins can be visualized
as smear high molecular weight bands in immunoblotting
using lysates from the cells treated with MG132 or other
proteasome inhibitors. The cell lysates were immunoprecipi-
tated using antibody against GADD45a (Supplement Figure 1,
lanes 1–4) or ubiquitin (Supplement Figure 1, lanes 5–8) and
then the proteins in the immune complexes were immunoblot-
ted with either anti-GADD45a antibody (Supplement
Figure 1, upper panel) or re-probed with anti-ubiquitin anti-
body after stripping (Supplement Figure 1, lower panel). As
can be seen in this figure, we did observe induction and
ubiquitination of GADD45a in the cells pre-treated with
MG132 in the absence of As3+. Treatment of the cells with
As3+ did not decrease, but rather increased the ubiquitination
of GADD45a protein. Thus, it is unlikely that As3+-induced
accumulation of GADD45a is through preventing the ubiqui-
tination of GADD45a protein.
As3+ stabilizes GADD45a mRNA through nucleolin
Next, we tested the possibility that As3+ might be able to
regulate the stability of GADD45a mRNA. To this end,
cells were incubated with or without 20 mM As3+ for 4 h before
Figure 3. As3+ induces accumulation of GADD45a mRNA. (A) The levels of
GADD45a mRNA and GAPDH mRNA were determined by RT–PCR using
cell lysates from the cells treated with 20 mM As3+ for the indicated times. The
sizes of PCR products were estimated by the DNA molecular marker (M) in
base pair (bp). The possible alternatively spliced fragments of GADD45a
mRNA were indicated as ‘b’ and ‘c’. Data are representative of at least three
experiments. (B) Fold changes in GADD45a expression were determined by
real-time RT–PCR. BEAS-2B cells were treated with 20 mM As3+ for the
indicated times and fold induction of the GADD45a mRNA was measured
by real-time RT–PCR as described in ‘Materials and Methods’.
Nucleic Acids Research, 2006, Vol. 34, No. 2 489
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/34/2/485/2401670 by guest on 20 July 2020
that the transcription was blocked by adding 5 mg/ml of acti-
nomycin D. The level of GADD45a mRNA was monitored
by quantitative RT–PCR after 0, 1, 2, 4 or 8 h of post-
actinomycin D treatment. As indicated in Figure 4A, the
GADD45a mRNA from untreated cells displayed a strong
reduction by almost 50% in the mRNA level after 8 h of
transcription inhibition. In contrast, more than 80%
GADD45a mRNA remained at this time point in the cells
treated with As3+, indicating that As3+ stabilizes GADD45a
mRNA substantially. The stability of the GAPDH mRNA was
Figure 4. As3+ stabilizes GADD45amRNA through nucleolin. (A) The stability of GADD45amRNA was determined by RT–PCR using the cell lysates from the
cells pre-treated with 20 mM As3+ for 4 h and then treated with 5 mg/ml of actinomycin D for the indicated times. (B) Cells were treated with 20 mM As3+ for the
indicated time and then subjected to western blotting for nucleolin, HuR, YB-1 and actin. The protein standard with the known molecular weights (kD) was used to
determine the positions of the indicated proteins on the membrane. (C) Cells were untreated or treated with 20mM As3+ in the absence or presence of 10mM Ly294002
(Ly) for 4 h and then disrupted with cell lysis buffer. Immunoprecipitation was performed with the antibodies against nucleolin (lanes 1–3), HuR (lanes 4–6) or IKKg
(lanes 7 and 8) at 4C for overnight and then treated with protein A-Agarose for an additional 4 h. The mRNAs of GADD45a and GAPDH in the immune complex (IP)
and cell lysates were determined by RT–PCR, respectively. The protein levels of nucleolin, HuR and IKKg in the immune complexes were determined by western
blotting (IP-WB). M: DNA marker. Data are representative of at least three experiments. (D) Immunofluorescence staining for the intracellular localization of
nucleolin and HuR. The BEAS-2B cells were untreated or treated with 20 mM As3+ for 4 h. The localization of nucleolin and HuR were determined by indirect
immunofluorescence using antibody against nucleolin or HuR and FITC-conjugated anti-rabbit IgG. The nuclei were stained by propidium iodide (PI).
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not affected by As3+. In fact, the GAPDH mRNA appears to be
relatively stable (Supplement Figure 2).
The stability for many inducible mRNAs is regulated by
a number of RNA-binding proteins that either stabilize or
destabilize mRNAs. In mammalian cells, the functional
characteristic of several mRNA stabilizing proteins, including
nucleolin, HuR and YB-1, has been extensively investigated.
To determine the involvement of these RNA-binding proteins
in the regulation of GADD45a mRNA, the expression of
nucleolin, HuR and YB-1 was investigated. As shown in
Figure 4B, the expression of nucleolin and HuR was detectable
under the basal condition. Addition of As3+ for 4, 8, 12 or 20 h
did not change the level of nucleolin (Figure 4B, top panel),
whereas the level of HuR was marginally decreased by As3+ in
a roughly time-dependent manner (Figure 4B, the second
panel). The expression of YB-1 was undetectable under the
conditions tested.
To determine the binding of nucleolin and HuR to
GADD45a mRNA, we next performed RNA immunoprecipi-
tation, an established method described in the literatures
(31,32), by using antibody against either nucleolin or HuR.
The mRNAs of GADD45a and GAPDH in the immune
complexes and the supernatants post-immunoprecipitation
were determined by RT–PCR. In agreement with the western
blotting data (Figure 4B), the amount of nucleolin in the
immune complexes was unchanged upon treatment of cells
with As3+, whereas the level of HuR was marginally reduced
after the treatment of As3+ (Figure 4C, bottom panel). Trace
amount of GADD45a mRNA in the control cells could be
co-precipitated by either anti-nucleolin or anti-HuR antibody,
indicating basal association of nucleolin and HuR with
GADD45a mRNA. Treatment of the cells with 20 mM
As3+ for 4 h increased the association of GADD45a with
nucleolin (Figure 4C, the panel of GADD45a in IP,
lane 2). As3+ was also capable of inducing the association
of GADD45a mRNA with HuR, although in a less potent
fashion compared with nucleolin (Figure 4C, the panel of
GADD45a in IP, lane 5). Since there are reports indicating
interconnection between PI3K-Akt and mRNA stability or
nucleolin (38–40), we then tested the possible involvement
of Akt signaling in the association of RNA-binding proteins
with the GADD45a mRNA. Pre-treatment of the cells with
Ly294002 inhibits phosphorylation of Akt (Figure 2). How-
ever, Ly294002 showed no effect on the As3+-induced
association of GADD45a mRNA with nucleolin or HuR
(Figure 4C, lanes 3 and 6). The association of GADD45a
mRNA with nucleolin and HuR appeared to be specific,
since there was no detectable GAPDH mRNA in the immune
complexes (Figure 4C, the panel of GAPDH in IP, lanes 1, 2, 4
and 5). A non-specific association of GAPDH mRNA with
either nucleolin or HuR was observed in the cells pre-treated
with Ly294002 alone (data not shown) or in the presence
of As3+ (Figure 4C, lanes 3 and 6). We also monitored the
levels of GADD45amRNA in the supernatants after immuno-
precipitation with anti-nucleolin and anti-HuR antibody,
respectively. The GADD45a mRNA was barely detected in
these supernatants (Figure 4C, the panel of GADD45a in
lysate), indicating that the majority of GADD45a mRNA
had been co-precipitated by immunoprecipitation for either
nucleolin or HuR. In a control experiment, we used an
antibody against IKKg in immunoprecipitation and found
no association of GADD45a mRNA with IKKg protein in
the cells without or with As3+ treatment (Figure 4C, top
panel, lanes 7 and 8). The basal and As3+-induced
GADD45a mRNAs remained in the cell lysates that had
been subjected to IKKg immunoprecipitation (Figure 4C,
the ‘GADD45 in lysate’ panel, comparing lanes 7 and 8
with lanes 1–6). Therefore, these data strongly suggest that
the stabilization of GADD45a mRNA by As3+ is through the
inducible binding of nucleolin and less potently, HuR to
GADD45a mRNA.
As3+ appeared to be very potent in inducing binding of
nucleolin to the GADD45a mRNA (Figure 4C). However,
As3+ was unable to influence the expression of nucleolin
(Figure 4B). Thus, it is worth testing whether the functional
aspect of nucleolin was modulated by As3+. For that purpose,
we investigated the intracellular location of nucleolin in the
cells without or with As3+ treatment by immunofluorescent
techniques. In control cells, nucleolin was concentrated in
nucleoli (Figure 4D, top panel). Following treatment of the
cells with 20 mM As3+ for 4 h, a notable intracellular
re-distribution of nucleolin from nucleoli to nucleoplasm
was observed (Figure 4D, bottom panel). In addition, some
As3+-treated cells showed cytoplasm staining of nucleolin. In
both control cells and the cells treated with As3+, the HuR
protein was localized throughout nucleoplasm and cytoplasm,
but was predominantly stained in nuclei (Figure 4D).
Nucleolin silencing reversed As3+-induced stabilization
of the GADD45a mRNA
To address the importance of nucleolin in As3+-induced
stabilization of the GADD45a mRNA, we next used small
interference RNA (siRNA) technique to knockdown nucleolin
and determined the mRNA stability of the GADD45a in the
cells treated with As3+. As indicated in Figure 5A, nucleolin
siRNA effectively reduced the level of nucleolin protein after
36 h of siRNA transfection, whereas the control siRNA against
luciferase showed no inhibition on the level of the nucleolin
protein. The data of mRNA stability analysis by a quantitative
RT–PCR showed a significant decrease in the stability of
the GADD45amRNA induced by As3+ in the cells transfected
with nucleolin siRNA (Figure 5B, comparing the control
siRNA with the nucleolin siRNA).
Finally, we examined the effect of nucleolin siRNA on
the induction of GADD45a protein induced by As3+. In agree-
ment with the observations in western blotting (Figures 1
and 2), immunofluorescent staining showed that the
GADD45a protein was undetectable in the cells without
As3+ treatment (Figure 5C, top panels). A substantial elevation
of nuclear-stained GADD45a protein was observed in the
cells treated with As3+ (Figure 5C, middle panels). Transfec-
tion of the cells with nucleolin siRNA partially diminished
the increase of GADD45a protein induced by As3+ (Figure 5C,
bottom panels).
DISCUSSION
In this report, we have provided evidence that As3+-induced
expression of GADD45a is through both transcriptional
and more importantly, post-transcriptional mechanisms: sta-
bilization of GADD45a mRNA. We have demonstrated that
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the accumulation of GADD45a mRNA induced by As3+ is
very likely due to the inducible binding of nucleolin, and less
potently, HuR, two RNA stabilizing proteins, to the
GADD45a mRNA. Silencing of nucleolin by an siRNA
specifically targeting nucleolin reversed As3+-induced stabil-
ization of the GADD45a mRNA and elevation of the
GADD45a protein.
A number of stress signals can induce accumulation of
GADD45a mRNA or protein. Oxidative stress due to the
generation of reactive oxygen species appears to be a
common feature in cellular responses to a variety of stress
signals, such as As3+- or inflammatory cytokine-induced stress
responses (30,41). It is plausible, therefore, to assume that the
induction of GADD45a by As3+ is mediated by oxidative
stress. Indeed, pre-treatment of the cells with antioxidants
prevented As3+-induced accumulation of GADD45a protein
(Figure 1). However, administration of the cells with the
exogenous reactive oxygen species, H2O2, only resulted in
a marginal induction of GADD45a (Figure 1B). The reporter
gene assay using GADD45a promoter and intron3 constructs
indicated that As3+ regulated GADD45a promoter and intron3
activity, whereas H2O2 only exhibited its effect on intron3
(Figure 1D). Thus, these data provide evidence indicating
that As3+-induced GADD45a is independent of oxidative
stress.
Transcriptional up-regulation appears to be the most impor-
tant and common mechanism in genes encoding stress
response proteins. The majority studies on the expression of
Figure 5. Knockdown of nucleolin reverses As3+-induced stabilization of the GADD45amRNA. (A) The BEAS-2B cells were transfected with the control siRNA
against firefly luciferase and the nucleolin siRNA for 24 h. The protein levels of nucleolin and actin were determined by western blotting. (B) Stability analysis of the
GADD45a mRNA in the cells treated with As3+ and transfected with the control or nucleolin siRNA. (C) Immunofluorescence staining for the expression of the
GADD45a protein. The BEAS-2B cells were first transfected with either the control siRNA or nucleolin siRNA for 36 h. Then the cells were either untreated or
treated with 20mM As3+ for 4 h. The expression of GADD45a protein was determined by indirect immunofluorescence using antibody against GADD45a and FITC-
conjugated anti-rabbit IgG (middle column). The cell morphology was shown as phase-contrast images (left column). The nuclei were stained by propidium iodide
(PI) (right column).
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GADD45a induced by a variety of stress signals focused on
the transcription of the GADD45a gene. The data presented in
this study suggest that As3+ has a very limited effect on the
transcription of the GADD45a gene, as can be seen in both
reporter gene activity analysis and nuclear run-on assay
(Figure 1D and data not shown). However, As3+ appeared
to be very capable of inducing a nucleolin-dependent stabil-
ization of the GADD45amRNA. These observations are com-
pensatory to a recent study by Fan et al. (42) who showed an
increased ratio of UVC-induced GADD45a mRNA transcript
versus UVC-induced transcription in a nuclear run-on assay
(Supplementary Table 2, row 938). The involvement of nucle-
olin in GADD45a mRNA stabilization was further verified by
siRNA-mediated gene knockdown of nucleolin, which
reversed As3+-induced stabilization of the GADD45a
mRNA. Immunoblotting and immunofluorescent staining
suggested that nucleolin was constitutively expressed in the
cells used in the present studies. Although As3+ exhibited
no influence on the expression of nucleolin protein, As3+
was able to induce intracellular re-distribution of nucleolin
from nucleoli to nucleoplasm. This could be an indication
in the functional up-regulation of nucleolin in response
to As3+, which contributes to the stabilization of the
GADD45a mRNA.
Several earlier reports suggested that UV, DNA-damaging
agents, retinoid CD437 or glutamine deprivation induced
GADD45a through stabilization of GADD45a mRNA in
Chinese hamster ovary cells or human breast carcinoma
cell lines (43–45). It was unclear, however, how the stability
of GADD45a mRNA was regulated in these cells under such
conditions. The findings that nucleolin and less potently,
HuR, bind to GADD45a mRNA in the cellular response
to As3+ (Figure 4C) provide a mechanistic explanation for
the stress-induced accumulation of GADD45a. Nucleolin is a
ubiquitous nucleolar phosphoprotein that consists of four
RNA-binding domains that are responsible for the binding
of this protein to pre-rRNA or mRNA (46). In addition,
nucleolin has also been implicated as the human helicase
IV that destabilizes helices of DNA–DNA, DNA–RNA
and RNA–RNA (47). Accumulating evidence indicates that
nucleolin is a key protein involved in the post-transcriptional
regulation of mRNAs. Previous studies by other laboratories
suggested that nucleolin was able to stabilize mRNAs of IL-2
(31), b-amyloid precursor protein (APP) (48), bcl2 (49), renin
(50) and CD154 (51). In response to T-cell activation,
nucleolin stabilizes IL-2 mRNA by interacting with the 50-
untranslated region (UTR) of IL-2 mRNA in a JNK-
dependent manner (31). Recently, we have demonstrated
an oxidative stress-mediated binding of nucleolin to mouse
GADD45a mRNA in mouse fibroblast cells (52). In an
in vitro analysis for the selection of mRNA ligands by nucle-
olin, Yang et al. (53) demonstrated a binding of nucleolin to
a number of other mRNAs, such as heat shock protein 90,
glutathione peroxidase, peroxiredoxin 1, etc. Several lines of
evidence indicate that nucleolin binds to pre-rRNA that
contains a consensus sequence, (U/G)CCCG(A/G), in a
loop of stem structure with 7–14 bp (54). Although the
recognition elements of nucleolin in the 50- or 30-UTR of
IL-2, APP, bcl2 and CD154 have been identified, no
consensus sequence or homology sequence has been found
in these mRNAs. Sequence comparison suggested that there
is no sequence similarity among the 50-UTRs of GADD45a
mRNA and the mRNAs of IL-2, APP, bcl2 or CD154.
However, it is interesting to note that both 50- and 30-UTR
of human GADD45a mRNA contain a potential stem–loop
with sequence, GCCCGG. This sequence matches completely
with the nucleolin recognition element, (T/G)CCCG(A/G), in
pre-rRNA (54).
Nucleolin has also been implicated in the cap-independent
but internal ribosome entry site (IRES)-dependent translation
of hepatitis C virus (55). Analysis of the 50-UTR region of
human GADD45a mRNA revealed a potential IRES domain
proximal to the AUG code. We have recently observed that
As3+ was also very potent in the induction of GADD45a
protein in the growth-arrested cells where the general protein
synthesis machinery was inhibited by rapamycin (data not
shown). This phenomenon is very likely due to the IRES-
dependent translational regulation. Whether nucleolin or
other factors participated in this process remains to be
investigated.
In summary, our data suggest that elevation in the expres-
sion of GADD45a in cellular response to As3+ is mainly
through the regulation of mRNA stability of GADD45a.
Treatment of the cells with As3+ increased binding of nucleolin
and to lesser extent, HuR to the mRNA of GADD45a, which
extends the half-life of GADD45a mRNA. It is unknown at
present how the association of nucleolin with the GADD45a
mRNA is regulated, despite we noted a re-distribution of
nucleolin protein from nucleoli to nucleoplasm in the cells
treated with As3+. Changes in mRNA stability have been
considered important mechanisms in which cells sense
stress or damage in concert with transcriptional and/or
other mechanisms. The contributions of GADD45a mRNA
stabilization to the cell cycle regulation and apoptosis are
currently under investigation.
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